Company Filing History:
Years Active: 2007
Title: The Innovations of Stephan Henke
Introduction
Stephan Henke is a notable inventor based in Tucson, AZ. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work at Aventis Pharmaceuticals Inc. His research focuses on developing new compounds that can have therapeutic effects.
Latest Patents
Stephan Henke holds 1 patent for his invention titled "Oxydecahydronaphthalene modulators of HM74." This patent involves the use of host cells expressing HM74 to obtain oxydecalin-like molecules with agonist activity. The structure of these molecules is designed to enhance their effectiveness in therapeutic applications.
Career Highlights
Throughout his career, Henke has demonstrated a commitment to advancing pharmaceutical research. His work at Aventis Pharmaceuticals Inc. has positioned him as a key player in the development of innovative treatments. His contributions have been recognized within the industry, showcasing his expertise and dedication.
Collaborations
Stephan Henke has collaborated with talented coworkers, including Anne Minnich and Theresa Kuntzweiler. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Stephan Henke's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent on oxydecahydronaphthalene modulators of HM74 highlights his contributions to developing new therapeutic agents. Through his career at Aventis Pharmaceuticals Inc., he continues to make strides in advancing medical science.